Viewing Study NCT04305795

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:43 PM
Ignite Modification Date: 2026-02-22 @ 9:55 AM
Study NCT ID: NCT04305795
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-06-19
First Post: 2020-03-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors
Sponsor: Rakuten Medical, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Head and Neck Squamous Cell Carcinoma View
None Metastatic Head-and-neck Squamous-cell Carcinoma View
None Locally Advanced Cutaneous Squamous Cell Carcinoma View
None Metastatic Cutaneous Squamous Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Rakuten Medical View
None ASP-1929 View
None HNSCC View
None CUSCC View
None head and neck View
None cutaneous View
None squamous cell carcinoma View
None photoimmunotherapy View
None PIT View
None skin View
None EGFR View
None Anti-PD1 View
None Pembrolizumab View
None Cemiplimab View